𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevalence of human papillomaviruses in urine samples of male patients infected with HIV-1 in Sao Paulo, Brazil

✍ Scribed by Fernando A.M. Costa; Roberto Carvalho da Silva; Liã B. Arruda; Alberto J.S. Duarte; Jorge Casseb


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
78 KB
Volume
81
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Human papillomavirus is a DNA virus that includes 118 genotypes. HPV16 is responsible for 80% of cervical cancer in women. Men are important reservoirs and major transmitters of HPV to their partners. The aim of this study was to detect HPV DNA and to determine the prevalence of HPV types 6, 11, 16, and 18 in urine samples of men infected with HIV‐1. This study included 223 patients infected with HIV‐1 from the Center of Reference on HIV/AIDS (CRT‐SP) and an outpatient clinic of HIV. Urine samples were collected and after DNA extraction real‐time PCR was performed for detection of HPV DNA. Positive samples were then tested by conventional PCR using type‐specific primers for the four HPV types. A total of 223 men infected with HIV‐1 were tested, 81% of whom were on HAART. Four (5.8%) were positive for HPV6, 18 (26.1%) were positive for HPV11, 22 (31.9%) were positive for HPV16 and five (7.2%) were positive for HPV18 by conventional PCR. Twenty (29%) patients had other HPV types and five patients (1.5%) had multiple types. The mean T CD4+cells count was 517 and 441 cells/mm^3^ (P = 0.30), in HPV negative and positive men, respectively. The HIV viral load was higher in the HPV negative group than for in the men with HPV (P = 0.0002). A 30.9% prevalence of HPV was found in asymptomatic urine samples of men infected with HIV‐1. This study suggests that urine may be a useful specimen for HPV screening. J. Med. Virol. 81:2007–2011, 2009. © 2009 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Prevalence of antibodies to recombinant
✍ S. Schwander; R. W. Braun; J. E. Kühn; F. T. Hufert; P. Kern; M. Dietrich; U. Wi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

## Abstract Two hundred twenty‐four sera were collected from 34 HIV‐1 infected patients during an observation period of up to 4.5 years (109 patient years of observation). The sera were tested for the presence of antibodies against the HIV‐1 virion infectivity factor (vif) protein. Thirty sera from

High prevalence of human T-lymphotropic
✍ Dr. Gianguglielmo Zehender; Chiara Colasante; Chiara De Maddalena; Flavia Bernin 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

## Abstract Human T‐lymphotropic virus type 1 and 2 (HTLV‐1 and HTLV‐2) infections in Europe are limited to intravenous drug users and migrants coming from areas in which they are endemic. A survey was undertaken of HTLV‐1 and HTLV‐2 infections in 393 recent immigrants: 167 HIV‐1 positive subjects

Prevalence of persistent and latent viru
✍ Lara Isobel Compston; Chengyao Li; Francis Sarkodie; Shirley Owusu-Ofori; Ohene 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

## Abstract Only limited epidemiological data, pertaining to the prevalence of common persistent viruses has been reported in Ghana. This study was conducted to determine the prevalence of persistent viruses in individuals with untreated HIV‐1 infection and uninfected blood donors. Paired plasma an

Prevalence of drug resistant mutants and
✍ Tamalet, Catherine; Pasquier, Christophe; Yahi, Nouara; Colson, Philippe; Poizot 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Baseline genotype resistance analysis was carried out in 48 adults with primary HIV-1 infection between 1995 and 1998 before starting early combination therapy. Seventeen percent (8/48) of the isolates displayed key mutations conferring resistance to reverse transcriptase (RT) inhibitors such as ami

FLOW CYTOMETRIC ANALYSIS OF THE TH1–TH2
✍ Ulrike Breytenbach; Anel Clark; Johan Lamprecht; Patrick Bouic 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 114 KB

## Abstract The Th1–Th2 balance plays a pivotal role in determining the outcome of an immune response to an infectious organism. It is proposed that during HIV infection, disease progression is characterized by a loss of Th1 activity, a shift to a more ‘allergic’ Th2‐type response and hence loss of